Hello world!
Welcome to WordPress. This is your first post. Edit or [...]
Welcome to WordPress. This is your first post. Edit or [...]
Collaboration
TJCC-Subcuject is seeking to out-license/divest IP to pharmaceutical- or device companies pursuing development of patient friendly combination solutions
Jesper Roested
CEO
Phone: +45 2122 7772
jesper@roested.dk
TJCC-Subcuject ApS
Olesvej 14
DK-2830 Virum
Denmark
VAT no: DK-4488809
